Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-20T11:21:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T10:18:16.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access to the study record is blocked. The standard site chrome remains visible, but the actual content is inaccessible, signaling a access restriction rather than a change to the study information.
    Difference
    19%
    Check dated 2026-09-22T12:24:54.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6. This indicates a minor platform/update change and does not modify study content.
    Difference
    0.1%
    Check dated 2026-08-31T23:58:53.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, replacing the previous version tag as part of a minor maintenance update to the page’s documentation/versioning.
    Difference
    0.1%
    Check dated 2026-08-10T13:43:50.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous v3.6.3 on the page. This indicates a minor update to the page's metadata or formatting rather than any change to the study details.
    Difference
    0.1%
    Check dated 2026-07-27T05:55:33.000Z thumbnail image

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.